Search details
1.
2-Step-Scores with optional nephropathology for the prediction of adverse outcomes for brain-dead donor kidneys in Eurotransplant.
Nephrol Dial Transplant
; 2024 Apr 17.
Article
in English
| MEDLINE | ID: mdl-38632055
2.
A paired-kidney allocation study found superior survival with HLA-DR compatible kidney transplants in the Eurotransplant Senior Program.
Kidney Int
; 104(3): 552-561, 2023 09.
Article
in English
| MEDLINE | ID: mdl-37343659
3.
Optimum timing of antithymocyte globulin in relation to adoptive regulatory T cell therapy.
Am J Transplant
; 23(1): 84-92, 2023 01.
Article
in English
| MEDLINE | ID: mdl-36695625
4.
Different roles of protein biomarkers predicting eGFR trajectories in people with chronic kidney disease and diabetes mellitus: a nationwide retrospective cohort study.
Cardiovasc Diabetol
; 22(1): 74, 2023 03 29.
Article
in English
| MEDLINE | ID: mdl-36991445
5.
Randomized Trial of Etelcalcetide for Cardiac Hypertrophy in Hemodialysis.
Circ Res
; 128(11): 1616-1625, 2021 05 28.
Article
in English
| MEDLINE | ID: mdl-33825489
6.
Sex differences in the survival benefit of kidney transplantation: a retrospective cohort study using target trial emulation.
Nephrol Dial Transplant
; 39(1): 36-44, 2023 Dec 20.
Article
in English
| MEDLINE | ID: mdl-37403325
7.
Early progression of chronic histologic lesions in kidney transplant biopsies is not associated with HLA histocompatibility.
Nephrol Dial Transplant
; 2023 Nov 13.
Article
in English
| MEDLINE | ID: mdl-37960919
8.
ImmunoDataAnalyzer: a bioinformatics pipeline for processing barcoded and UMI tagged immunological NGS data.
BMC Bioinformatics
; 23(1): 21, 2022 Jan 06.
Article
in English
| MEDLINE | ID: mdl-34991455
9.
Lessons from effect of etelcalcetide on left ventricular hypertrophy in patients with end-stage kidney disease.
Curr Opin Nephrol Hypertens
; 31(4): 339-343, 2022 07 01.
Article
in English
| MEDLINE | ID: mdl-35703173
10.
Patient-Reported Outcomes as Endpoints in Clinical Trials of Kidney Transplantation Interventions.
Transpl Int
; 35: 10134, 2022.
Article
in English
| MEDLINE | ID: mdl-35669971
11.
Alloimmune Risk Stratification for Kidney Transplant Rejection.
Transpl Int
; 35: 10138, 2022.
Article
in English
| MEDLINE | ID: mdl-35669972
12.
Surrogate Endpoints for Late Kidney Transplantation Failure.
Transpl Int
; 35: 10136, 2022.
Article
in English
| MEDLINE | ID: mdl-35669974
13.
Proposed Definitions of T Cell-Mediated Rejection and Tubulointerstitial Inflammation as Clinical Trial Endpoints in Kidney Transplantation.
Transpl Int
; 35: 10135, 2022.
Article
in English
| MEDLINE | ID: mdl-35669975
14.
Allograft Function as Endpoint for Clinical Trials in Kidney Transplantation.
Transpl Int
; 35: 10139, 2022.
Article
in English
| MEDLINE | ID: mdl-35669976
15.
Proposed Definitions of Antibody-Mediated Rejection for Use as a Clinical Trial Endpoint in Kidney Transplantation.
Transpl Int
; 35: 10140, 2022.
Article
in English
| MEDLINE | ID: mdl-35669973
16.
Rationale for Surrogate Endpoints and Conditional Marketing Authorization of New Therapies for Kidney Transplantation.
Transpl Int
; 35: 10137, 2022.
Article
in English
| MEDLINE | ID: mdl-35669977
17.
Trajectories of glomerular filtration rate and progression to end stage kidney disease after kidney transplantation.
Kidney Int
; 99(1): 186-197, 2021 01.
Article
in English
| MEDLINE | ID: mdl-32781106
18.
Precision medicine in transplantation and hemodialysis.
Nephrol Dial Transplant
; 36(Suppl 2): 31-36, 2021 06 22.
Article
in English
| MEDLINE | ID: mdl-34153984
19.
Long-term risks after kidney donation: how do we inform potential donors? A survey from DESCARTES and EKITA transplantation working groups.
Nephrol Dial Transplant
; 36(9): 1742-1753, 2021 08 27.
Article
in English
| MEDLINE | ID: mdl-33585931
20.
Organ transplants of the future: planning for innovations including xenotransplantation.
Transpl Int
; 34(11): 2006-2018, 2021 Nov.
Article
in English
| MEDLINE | ID: mdl-34459040